293 posters, 56 videos, 24 topics, 13 sessions, 658 authors, 215 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
ISMICS 2025 Annual Meeting
28 - 31 May, 2025 | Istanbul, Turkey

D132
Is Right Mini-thoracotomy An Economic And A Safe Approach For Mitral Valve Surgery?
Poster Presenter
Part of Topic
Valve – Surgical Valves
Authors:
Mohammed Abdelfattah Sanad 1, Hatem Beshir 1, Mohamed Gabr 1, Gehad Awad 1, Fetouh Aladdin 1, Mahmoud Ahmed 1, Amir Bastawisy 2.
The increasing interest in minimally invasive approaches has induced fast expansion of minimally invasive mitral valve surgery (MIMVS) over the past two decades. It is well established that MIMVS reduce blood loss, ventilation time and postoperative pain as well as shorter ICU and hospital stays in comparison to conventional surgery. MIMVS need special instruments, disposables and setup that may be costly in some of the developing countries. However, right mini thoracotomy (RMT) approach may have all the advantages of the MIMVS with a slight difference in the length of the wound and less cost.
Methods:
This retrospective cohort multi-centric study has been conducted in 3 cardiac surgery referral centers in Egypt. Eligible were 80 patients who underwent isolated mitral valve surgery using (RMT) approach . Excluded were patients who needed other concomitant cardiac procedures, redo cases and patients who had pulmonary pathology or previous exposure to irradiations.
Results:
Our study include 68% female patients with mean age was +/- 34 years old. All our patients had a rheumatic mitral valve pathology with 65% of them with mitral stenosis. Mean incision length was 6 +/- 0.6 cm. One case had diaphragmatic eventration. Three patients had pericardial adhesions, and 5 cases had high drainage who were conservatively managed. No conversion to sternotomy, re-exploration for bleeding or mortality were recorded.
Conclusion:
RMT approach via central cannulation is a safe method with a comparable skin incision to the classical MIMVS. But with a marked cost difference especially in a developing country with no effect regarding major adverse cardiac events.
